|
2017 Conference Publication Diagnostic potential of PSMA PET in advanced renal cell carcinomaNicholson, C., Joshi, A., Rhee, H., Tham, M., Thomas, P., Blazak, J., Samaratunga, H., Ng, K. L., Globe, G., Vela, I. and Wood, S. (2017). Diagnostic potential of PSMA PET in advanced renal cell carcinoma. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750 |
|
2017 Journal Article Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer RotterdamEgevad, Lars, Samaratunga, Hemamali and Delahunt, Brett (2017). Editorial comment to biopsy undergrading in men with Gleason score 6 and fatal prostate cancer in the European Randomized study of Screening for Prostate Cancer Rotterdam. International Journal of Urology, 24 (4), 286-287. doi: 10.1111/iju.13305 |
|
2017 Journal Article Prostate cancer grading: a decade after the 2005 modified Gleason grading systemDelahunt, Brett, Grignon, David J., Samaratunga, Hemamali, Srigley, John R., Leite, Katia R. M., Kristiansen, Glen, Evans, Andrew J., Kench, James G. and Egevad, Lars (2017). Prostate cancer grading: a decade after the 2005 modified Gleason grading system. Archives of Pathology and Laboratory Medicine, 141 (2), 182-183. doi: 10.5858/arpa.2016-0300-LE |
|
2017 Conference Publication Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cellsNicholson, C., Rhee, H., Ng, K. L., Tse, B. W., Yeh, M-C, Russell, P., Nelson, C., Thomas, P., Samaratunga, H., Vela, I., Gobe, G. and Wood, S. (2017). Expression of prostate specific membrane antigen in clear cell renal cell carcinoma, neovasculature of tumour, and circulating tumour cells. 70th Annual Scientific Meeting of the Urological Society of Australia and New Zealand, Canberra, ACT Australia, 24-27 February 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/bju.13750 |
|
2016 Journal Article Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et alEgevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Editorial statement on Gleason scoring for prostate cancer: in regard to Zietman et al. International Journal of Radiation Oncology - Biology - Physics, 96 (5), 1126-1127. doi: 10.1016/j.ijrobp.2016.08.029 |
|
2016 Journal Article New Gleason grading system: statement from the editors of 6 journalsEgevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). New Gleason grading system: statement from the editors of 6 journals. Urologic Oncology: Seminars and Original Investigations, 34 (11), 479-480. doi: 10.1016/j.urolonc.2016.07.003 |
|
2016 Journal Article Reply by the authorsEgevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Reply by the authors. Urology, 96, 179-180. doi: 10.1016/j.urology.2016.07.006 |
|
2016 Journal Article Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced diseaseRhee, Handoo, Ng, Keng Lim, Tse, Brian Wan-Chi, Yeh, Mei-Chun, Russell, Pamela J., Nelson, Colleen, Thomas, Paul, Samaratunga, Hemamali, Vela, Ian, Gobe, Glenda and Wood, Simon (2016). Using prostate specific membrane antigen (PSMA) expression in clear cell renal cell carcinoma for imaging advanced disease. Pathology, 48 (6), 613-616. doi: 10.1016/j.pathol.2016.05.011 |
|
2016 Journal Article One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason gradingSrigley, John R., Delahunt, Brett, Egevad, Lars, Samaratunga, Hemamali, Yaxley, John and Evans, Andrew J. (2016). One is the new six: the international society of urological pathology (ISUP) patient-focused approach to Gleason grading. Canadian Urological Association Journal, 10 (9-10), 339-341. doi: 10.5489/cuaj.4146 |
|
2016 Journal Article Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 studyYaxley, John W., Coughlin, Geoffrey D., Chambers, Suzanne K., Occhipinti, Stefano, Samaratunga, Hema, Zajdlewicz, Leah, Dunglison, Nigel, Carter, Rob, Williams, Scott, Payton, Diane J., Perry-Keene, Joanna, Lavin, Martin F. and Gardiner, Robert A. (2016). Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study. The Lancet, 388 (10049), 1057-1066. doi: 10.1016/S0140-6736(16)30592-X |
|
2016 Journal Article Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologistsKweldam, Charlotte F., Nieboer, Daan, Algaba, Ferran, Amin, Mahul B., Berney, Dan M., Billis, Athanase, Bostwick, David G., Bubendorf, Lukas, Cheng, Liang, Comperat, Eva, Delahunt, Brett, Egevad, Lars, Evans, Andrew J., Hansel, Donna E., Humphrey, Peter A., Kristiansen, Glen, van der Kwast, Theodorus H., Magi-Galluzzi, Cristina, Montironi, Rodolfo, Netto, George J., Samaratunga, Hemamali, Srigley, John R., Tan, Puay H., Varma, Murali, Zhou, Ming and van Leenders, Geert J. L. H. (2016). Gleason grade 4 prostate adenocarcinoma patterns: an interobserver agreement study among genitourinary pathologists. Histopathology, 69 (3), 441-449. doi: 10.1111/his.12976 |
|
2016 Journal Article From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancerSamaratunga, Hemamali, Delahunt, Brett, Yaxley, John, Srigley, John R. and Egevad, Lars (2016). From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer. Scandinavian Journal of Urology, 50 (5), 325-329. doi: 10.1080/21681805.2016.1201858 |
|
2016 Journal Article Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocolRoberts, Matthew J., Yaxley, John W., Coughlin, Geoffrey D., Gianduzzo, Troy R. J., Esler, Rachel C., Dunglison, Nigel T., Chambers, Suzanne K., Medcraft, Robyn J., Chow, Clement W. K., Schirra, Horst Joachim, Richards, Renee S., Kienzle, Nicholas, Lu, Macy, Brereton, Ian, Samaratunga, Hema, Perry-Keene, Joanna, Payton, Diane, Oyama, Chikara, Doi, Suhail A., Lavin, Martin F. and Gardiner, Robert A. (2016). Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol. Contemporary Clinical Trials, 50, 16-20. doi: 10.1016/j.cct.2016.06.014 |
|
2016 Journal Article Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkersRoberts, Matthew J., Richards, Renee S., Chow, Clement W. K., Doi, Suhail A. R., Schirra, Horst Joachim, Buck, Marion, Samaratunga, Hemamali, Perry-Keene, Joanna, Payton, Diane, Yaxley, John, Lavin, Martin F. and Gardiner, Robert A. (2016). Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International, 4 (3), 97-102. doi: 10.1016/j.prnil.2016.04.002 |
|
2016 Journal Article Consensus guidelines for reporting prostate cancer Gleason GradeEgevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Consensus guidelines for reporting prostate cancer Gleason Grade. BJU International, 118 (3), E1-E2. doi: 10.1111/bju.13596 |
|
2016 Journal Article A systematic review and meta-Analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytomaNg, Keng Lim, Morais, Christudas, Bernard, Anne, Saunders, Nicholas, Samaratunga, Hemamali, Gobe, Glenda and Wood, Simon (2016). A systematic review and meta-Analysis of immunohistochemical biomarkers that differentiate chromophobe renal cell carcinoma from renal oncocytoma. Journal of Clinical Pathology, 69 (8), 661-671. doi: 10.1136/jclinpath-2015-203585 |
|
2016 Journal Article Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological featuresSeipel, Amanda H., Delahunt, Brett, Samaratunga, Hemamali and Egevad, Lars (2016). Ductal adenocarcinoma of the prostate: histogenesis, biology and clinicopathological features. Pathology, 48 (5), 398-405. doi: 10.1016/j.pathol.2016.04.001 |
|
2016 Journal Article Reply: Gleason and Fuhrman no longer make the gradeDelahunt, Brett, Egevad, Lars, Samaratunga, Hemamli, Martignoni, Guido, Nacey, John N. and Srigley, John R. (2016). Reply: Gleason and Fuhrman no longer make the grade. Histopathology, 69 (2), 341-342. doi: 10.1111/his.12947 |
|
2016 Journal Article Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Re: Anthony Zietman, Joseph Smith, Eric Klein, Michael Droller, Prokar Dasgupta, James Catto. Describing the Grade of Prostate Cancer: Consistent Use of Contemporary Terminology Is Now Required. Eur Urol 2016;70:1. European Urology, 71 (2), e52-e53. doi: 10.1016/j.eururo.2016.07.019 |
|
2016 Journal Article Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016; 195: 1723Egevad, Lars, Samaratunga, Hemamali, Srigley, John R. and Delahunt, Brett (2016). Re: Consensus Guidelines for Reporting Prostate Cancer Gleason Grade: A. Zietman, E. Klein, M. J. Droller, P. Dasgupta, J. Catto and J. A. Smith, Jr. J Urol 2016; 195: 1723. Journal of Urology, 196 (4), 1321-1323. doi: 10.1016/j.juro.2016.07.069 |
